Clinical Trials Directory

Trials / Completed

CompletedNCT02459106

Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
AdventHealth Translational Research Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is examine the effect of fat tissue-released miRNA on skeletal muscle and if abnormal fat tissue-released miRNA contributes to insulin resistance in obese individuals. This information will be important for our understanding of how the body's sugar metabolism is regulated and why people who are obese become insulin resistant and are more likely to develop type 2 diabetes.

Detailed description

Study Objectives: 1. To establish and optimize the methodology for measuring adipose tissue miRNA release. 2. To establish and optimize the methodology for measuring the effect of adipose tissue-released miRNA on skeletal muscle biology and insulin sensitivity. 3. To profile adipose tissue-released miRNA in lean insulin-sensitive and obese insulin-resistant healthy individuals. 4. To examine the effects of adipose tissue-released miRNA from lean insulin-sensitive individuals and obese insulin-resistant individuals on skeletal muscle biology and insulin sensitivity.

Conditions

Timeline

Start date
2015-05-27
Primary completion
2017-01-24
Completion
2024-12-19
First posted
2015-06-01
Last updated
2025-03-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02459106. Inclusion in this directory is not an endorsement.